Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Restructuring Costs: 2019-2024

Historic Restructuring Costs for Pediatrix Medical (MD) over the last 6 years, with FY2024 value amounting to $64.3 million.

  • Pediatrix Medical's Restructuring Costs fell 6792.03% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year decrease of 6267.94%. This contributed to the annual value of $64.3 million for FY2024, which is 279589.91% up from last year.
  • As of FY2024, Pediatrix Medical's Restructuring Costs stood at $64.3 million, which was up 279589.91% from $2.2 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Restructuring Costs ranged from a high of $73.8 million in FY2020 and a low of $2.2 million during FY2023
  • For the 5-year period, Pediatrix Medical's Restructuring Costs averaged around $37.9 million, with its median value being $27.3 million (2022).
  • Per our database at Business Quant, Pediatrix Medical's Restructuring Costs crashed by 9187.54% in 2023 and then soared by 279589.91% in 2024.
  • Over the past 5 years, Pediatrix Medical's Restructuring Costs (Annual) stood at $73.8 million in 2020, then crashed by 70.05% to $22.1 million in 2021, then increased by 23.58% to $27.3 million in 2022, then tumbled by 91.88% to $2.2 million in 2023, then soared by 2795.9% to $64.3 million in 2024.
  • Its Restructuring Costs stands at $64.3 million for FY2024, versus $2.2 million for FY2023 and $27.3 million for FY2022.